PRESS RELEASES

Lochlin Partners Places Preethi Bapna As Chief of Staff at Editas Medicine (Nasdaq: EDIT)

Preethi Bapna has been named Chief of Staff at Editas Medicine (Nasdaq: EDIT). Editas is a clinical stage genome editing company dedicated to developing transformative genomic medicines to treat a broad range of serious diseases. Preethi brings a diversity of experiences from her time in consulting and across her roles in life sciences. She most recently served as Head of Consulting & Integration Management at Novo Nordisk Inc.